Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
International Prospective Umbrella Trial for Children with ATRT
DRKS00023783Phase 3Recruiting
- Sponsor
- German Society for Pediatric Oncology and Hematology
- Start
- Sep 2021
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 14
01
Overview
Phase 3, randomised trial of carboplatin and thiotepa in Atypical teratoid rhabdoid tumor (ATRT) and Neuro-Oncological Malignancies (2 arms), sponsored by German Society for Pediatric Oncology and Hematology. Primary endpoint: Non-inferiority of high-dose chemotherapy versus focal radiotherapy as consolidation. Started Sep 2021; status: recruiting.
02
Drugs
carboplatinthiotepa
03
Conditions
Atypical teratoid rhabdoid tumor (ATRT)Neuro-Oncological Malignancies
Beyond the preview
Go deeper on DRKS00023783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00023783.